Posted in | News | Medical Robotics

Hansen Medical’s Magellan Robotic System Receives FDA Clearance

Hansen Medical recently declared that its Magellan Robotic System, inclusive of catheter and accessories, has achieved 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Following this clearance, the company will instantly start commercialization at specific centers across the U.S. However, its full launch is scheduled in 2012 end. The product will be demonstrated from June 7 to 9 at the 66th Vascular Annual Meeting of the Society for Vascular Surgery at National Harbor, Maryland.

The Magellan Robotic System ensures efficient access across anatomical targets within the peripheral vasculature followed by creating a conduit for therapeutic devices that can be placed manually. Using this unique system, vascular surgeons can rapidly perform predictable procedures without being affected by radiation exposure.

Among 3 M vascular procedures accomplished each year, around one-third to one-half of deploy the Magellan Robotic System.

A new standard for peripheral vascular intervention has been created by the Magellan Robotic System. It features solid catheter stability, revolutionary lesion access, consistent procedural efficiency and precise distal tip control.

The Magellan platform will ensure hospitals with compelling value proposition.

In 2011, the Magellan System achieved a CE Mark in the EU, followed by commercial launch in that state. The system has received approval in Australia, with a pending approval in Canada.

Based on the flexible robotic technology integrated in the Sensei-X Robotic Catheter System, Hansen Medical's Magellan Robotic System features increased case throughput ensuring predictable procedure times; maintains Sensei System’s open architecture enabling subsequent use of many 6F therapeutic devices on the existing market; and offers solid catheter stability for placing therapeutic devices. Furthermore, it ensures independent robotic control of the distal tips of inner leader catheter and outer sheath in addition to robotic manipulation of standard guidewires. It can be extended inside the body to navigate complex peripheral anatomy.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kaur, Kalwinder. (2019, February 20). Hansen Medical’s Magellan Robotic System Receives FDA Clearance. AZoRobotics. Retrieved on November 25, 2024 from https://www.azorobotics.com/News.aspx?newsID=2871.

  • MLA

    Kaur, Kalwinder. "Hansen Medical’s Magellan Robotic System Receives FDA Clearance". AZoRobotics. 25 November 2024. <https://www.azorobotics.com/News.aspx?newsID=2871>.

  • Chicago

    Kaur, Kalwinder. "Hansen Medical’s Magellan Robotic System Receives FDA Clearance". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=2871. (accessed November 25, 2024).

  • Harvard

    Kaur, Kalwinder. 2019. Hansen Medical’s Magellan Robotic System Receives FDA Clearance. AZoRobotics, viewed 25 November 2024, https://www.azorobotics.com/News.aspx?newsID=2871.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.